Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 81

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 81
---
 exchange or market or automated quotation system.

Additionally,
none of the depositary, the custodian or us, or any of their or our respective directors, officers, employees, agents or affiliates shall
be liable for the failure by any registered holder of ADRs or beneficial owner to obtain the benefits of credits or refunds of non-U.S.
tax paid against such ADR holder’s or beneficial owner’s income tax liability. The depositary is under no obligation to provide
the ADR holders and beneficial owners, or any of them, with any information about our tax status. None of us, the depositary, the custodian
or any of our or their respective directors, officers, employees, agents or affiliates shall incur any liability for any tax or tax consequences
that may be incurred by registered ADR holders or beneficial owners on account of their ownership or disposition of ADRs or Depositary
Shares.

Neither the depositary
nor its agents will be responsible for any failure to carry out any instructions to vote any of the deposited securities, for the manner
in which any voting instructions are given, including instructions to give a discretionary proxy to a person designated by us, for the
manner in which any vote is cast, including, without limitation, any vote cast by a person to whom the depositary is instructed to grant
a discretionary proxy pursuant to the terms of the Deposit Agreement, or for the effect of any such vote. The depositary shall endeavor
to effect any sale of securities or other property and any conversion of currency, securities or other property, in each case as is referred
to or contemplated in the Deposit Agreement or the form of ADR, in accordance with the depositary’s normal practices and procedures
under the circumstances applicable to such sale or conversion, but shall have no liability (in the absence of its own willful default
or gross negligence or that of its agents, officers, directors or employees) with respect to the terms of any such sale or conversion,
including the price at which such sale or conversion is effected, or if such sale or conversion shall not be practicable, or shall not
be believed, deemed or determined to be practicable by the depositary. Specifically, the depositary shall not have any liability for
the price received in connection with any public or private sale of securities (including, without limitation, for any sale made at a
nominal price), the timing thereof or any delay in action or omission to act nor shall it be responsible for any error or delay in action